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What Topic?
•

SARS-CoV-2 (COVID-19)

A Virus that primarily affects the
respiratory tract (Yuki et al., 2020)

•

Why SARS-CoV-2?
•

•
•

•

Over 18 million people have been
infected by the virus in the span of
a year. Labeling this virus a global
pandemic (Nikose et al., 2020).
Symptoms for COVID-19 range
from mild to severe with end organ
failure (Yuki et al., 2020).
34,067,912 confirmed cases and
608,884 deaths in the United States
alone (John Hopkins University of
Medicine, 2021)

Dailr new confirmed COVID-19 deaths per million people

=~~-::.:::-...·:::::=::::.-..... - ..- -

•

•

-

•

COVID-19 enters the body via close
contact or an individual coughing
the viral particles into the air.
The virus binds to the host cells
and enters the cell by endocytosis
and replicates it RNA, which makes
viral proteins.
COVID-19 virus has a spike that
comprises of two functional
subunits:
•
S1: responsible for
binding to the cell.
•
S2: causes fusion
between viral
proteins and cellular
membrane
In the lungs angiotensin enzyme is
a functional receptor site for
COVID-19. The lungs are the
primary organ affected by the
virus.
(Yuki et. al., 2021)

Significance Of
Pathology
•
(COVID-19 confirmed deaths, Our World
In Data, 2021)

Signs & Symptoms

•

•
•
•
•
•
•
•

Symptoms range from no
symptoms to severe adult
respiratory distress syndrome
(ARDS)

Common clinal symptoms include:
Fever
Cough
Dyspnea
Myalgia
Fatigue
(Binda et al., 2021)

•

•

•

•
•

•

•

•

•
•

COVID-19 can be transmitted from
human to human, when a healthy
individual comes in contact with an
infected person.

•
•
•

Can spread from asymptomatic or
symptomatic individuals.

•

Transmission and spread is seen
initially from family members and then
healthcare workers who come in
contact with infected persons.

I

Preventing the spread of the virus
requires frequent hand washing or
utilization of 70% (V/V) alcohol based
hand sanitizer.

•

(Nikose et al., 2020)

(Binda et al., 2021)
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•

Three vaccinations have come on the
market to decrease spread and
mortality rates, if COVID-19 is
acquired.

•

Pfizer, Moderna, and Johnson &
Johnson have been approved by FDA
(emergency).

•

Both Pfizer and Moderna utilize new
techniques, such as nucleic acid (DNA
& RNA)

•

(Nikose et al., 2020)
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(Allorhythmia for
Prone Position
Therapy, Binda et
al., 2021)

•
•

(Prone Position,
Binda et al., 2021)

•

Ventilator support or
CPAP/BIPAP/HHF
Plasma Therapy
Antiviral treatment

•

Transmission of COVID-19 into
Lung and kidney tissue,
(Pesaresi et al., 2020)

•

Prone Position Therapy
Can be used with non-ventilated or
ventilated patients.
Promotes better oxygen exchange
•
Pulmonary Recruitment
•
Increases Lung Volume
•
Reduces Atelectatic
Regions
Preparations Prior to proning:
•
Secure endotracheal
Tube (if applicable).
•
Lubricate eyes
•
Applying Hydrocolloid
dressings to protect skin
(Binda et. al., 2021)
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•
•

•

•

•

•

Intubated patients require six total
healthcare works to perform safely:
•
4 Nurses
•
1 Respiratory Therapist
•
1 provider that can
reintubate if necessary
Continuous monitoring while prone:
•
SpO2
•
Arterial Line
•
End-Tidal Carbon
Dioxide
•
(Minimal Requirement)
(Binda et. al., 2021)

•

•
•

COVID-19 can have a number of
complications.

Respiratory failure/ARDS requiring
ventilatory support (Jackson &
Wands, 2021)
End organ failure:
•
Kidneys
•
Heart
•
Brain

Additional services maybe needed
to treat and manage organ failure:
•
•
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Care for COVID-19 patients:

Supportive care and managing
symptoms:
•
Fever (Tylenol, ice
packs, etc.)
•
Dyspnea (Oxygen)
•
Cough
•
Muscle Aches
(Motrin)
Phycological Support from being
isolated from family and support
system.
•
Virtual Calls
•
Phone accessibility

Constant monitoring of symptoms
progression (mild to severe).
(Centers for Disease Control and
Prevention [CDC], 2021)

CRRT
Swan-gantz catheter
placement
Anticoagulation
Computerized
Tomography (CT)
scan

•

(Yuki et. al., 2021)

•

COVID-19 is a virus that has
impacted millions around the
world causing a global pandemic.

•

Nursing Care
Figure! Pronepatientinswimmerposition.

•
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Complications of
COVID-19

•

Vaccines approved by FDA, (Center
for Disease Control and Prevention
[CDC], 2021)
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This pathology guides are clinical
decisions and treatment plans:

(Nikose et. al., 2020).

•

Severe Cases of COVID-19:
Respiratory failure/ARDS
Supplemental Oxygen:
•
Ventilator Support
•
Noninvasive Oxygen
Strategy (NIOS)
•
i.e. CPAP/BIPAP and
Heated High Flow.
Continuous Renal Replacement
Therapy
Prone Position technique

---

(Nikose et. al., 2020)

Knowing this provides
understanding to the disease
process and the symptoms
associated with the virus.
•
Dyspnea
•
Fever (host response
to infection)
•
Low partial pressure
of oxygen (PaO2)

•
•

•
•
•

Several different treatment options
once the virus has been contracted
Antivirals
•
Remdesivir
•
Oseltamivir
•
Umifenovir
Steroids
Plasma Therapy
Supplemental Oxygen support

Vaccinations

f1

Spreading of the virus can be external
(family members/community) or in
the body leading to end organ failure
via the bloodstream or lymphatic
system.

The pathology of this virus impacts
the lungs, by attaching to one of the
major enzymes ACE2 (Yuki et. al.,
2021).

•

•

Treatment

Transmission
&
Spread

•

•

•

References

Conclusion

The virus primarily impacts the
lungs, but can have a multiorgan
impact with patients (Pesaresi et.
al., 2020).

Several treatment options are
available to support mild or severe
cases of COVID-19:
•
Vaccines
•
Antivirals
•
Ventilatory support
•
Prone Therapy
•
NSAIDS
•
(Nikose et. al., 2020)

Three vaccines have been approved
by the FDA (emergently) to slow
the spread of COVID-19 and
decrease mortality rates of those
that contract the virus (Nikose et.
al., 2020).
COVID-19 can have many
complications and requires
supportive care and phycological
support for patients hospitalized.
(Centers for Disease Control and
Prevention [CDC], 2021)
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